Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization.
von König
C H
CH
Institut für Hygiene und Laboratoriumsmedizin, Klinikum Krefeld, Germany. WvKoenig@t-online.de
Herden
P
P
Palitzsch
D
D
Schneeweiss
B
B
Bier
N
N
D000907:Antibodies, Bacterial / Q000032:analysis*; D001886:Bordetella pertussis / Q000276:immunology*; D016001:Confidence Intervals; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007273:Injections, Intramuscular; D008297:Male; D010567:Pertussis Vaccine / Q000008:administration & dosage*; D012016:Reference Values; D022282:Vaccines, Acellular / Q000008:administration & dosage; D014917:Whooping Cough / Q000276:immunology* / Q000517:prevention & control*
D000907:Antibodies, Bacterial; D010567:Pertussis Vaccine; D022282:Vaccines, Acellular